Thomas Pisansky, MD | Authors


Practice Apoptosis: When Partners Retire

May 14, 2010

Kicking off the first in a series of podcasts, a noted healthcare consultant discusses how retirement can fracture a practice.

Developing a Prognostic Model for Individual Prostate Cancer Patients

November 01, 1997

The outcome of 500 patients treated solely with irradiation for clinical stages T1-T4, N0, M0 prostatic carcinoma was used to develop an enhanced prognostic system for patients with clinically localized prostatic cancer. Clinical tumor stage, Gleason score, and pretherapy prostate-specific antigen (PSA) were independently associated with clinical or biochemical relapse and included in a risk score equation that defined patient groups with distinctly different outcomes. [Oncol News Int 6(Suppl 3):8-9, 1997]